Zogenix is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
REPORT RATINGS
4.8 / 5.0 (160)
Zogenix reports have an aggregate usefulness score of 4.8 based on 160 reviews.